NCI Proposes Inviting Academic Labs To Submit New Therapies For Development
In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm
“Action Steps” Listed For Prostate Research In National Blueprint
Screening Guidelines Differ Among Major Medical Organizations
NCI Says Review Group Will Read Blueprint, Evaluate NCI Research
Cancer Policy: Board Advocates $2 Per Pack Raise For Cigarettes
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition









